A trailblazer in genetic identification and treatment for rare disorders
Dr. Rockman-Greenberg developed an early interest in rare and ultrarare genetic disorders, which led to a career in pediatrics and medical genetics. As an academic clinician, she focused her research on applied molecular genetics and the identification of the molecular basis of genetic disorders overrepresented in unique populations, notably hypophosphatasia (HPP), a metabolic bone disorder, and glutaric aciduria type 1 (GA1), a complex disorder of organic acid metabolism, affecting Mennonite and Indigenous populations respectively. Working closely with the communities themselves, she has carried advanced knowledge and skills from the research facilities of major universities directly to people who need them.
